Cargando…

Multi-omic Dissection of Oncogenically Active Epiproteomes Identifies Drivers of Proliferative and Invasive Breast Tumors

Proliferative and invasive breast tumors evolve heterogeneously in individual patients, posing significant challenges in identifying new druggable targets for precision, effective therapy. Here we present a functional multi-omics method, interaction-Correlated Multi-omic Aberration Patterning (iC-MA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wrobel, John A., Xie, Ling, Wang, Li, Liu, Cui, Rashid, Naim, Gallagher, Kristalyn K., Xiong, Yan, Konze, Kyle D., Jin, Jian, Gatza, Michael L., Chen, Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660457/ https://www.ncbi.nlm.nih.gov/pubmed/31336272 http://dx.doi.org/10.1016/j.isci.2019.07.001

Ejemplares similares

Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications
por: Song, Huibin, et al.
Publicado: (2020)

A benchmark dataset for analyzing and visualizing the dynamic epiproteome
por: Kaur, Sandeep, et al.
Publicado: (2019)

Pathogens and Disease Play Havoc on the Host Epiproteome—The “First Line of Response” Role for Proteomic Changes Influenced by Disorder
por: Rikkerink, Erik H. A.
Publicado: (2018)

KDM1A Identified as a Potential Oncogenic Driver and Prognostic Biomarker via Multi-Omics Analysis
por: Li, Lingyue, et al.
Publicado: (2021)

A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer
por: Kelly, Michael R., et al.
Publicado: (2022)

Oncogenic drivers and mitochondrial dependency
por: Alvarez-Calderon, Francesca, et al.
Publicado: (2015)

R‐spondin‐3 is an oncogenic driver of poorly differentiated invasive breast cancer
por: ter Steege, Eline J, et al.
Publicado: (2022)

Dissecting apoptosis the omics way
por: Van Damme, Petra
Publicado: (2013)

Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer
por: Khella, Christen A., et al.
Publicado: (2021)

Oncogenic driver mutations in lung cancer
por: Luo, Susan Y, et al.
Publicado: (2013)

Subretinal Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy
por: Dalma-Weiszhausz, Jose, et al.
Publicado: (2012)

OmicsON – Integration of omics data with molecular networks and statistical procedures
por: Turek, Cezary, et al.
Publicado: (2020)

wtf genes are prolific dual poison-antidote meiotic drivers
por: Nuckolls, Nicole L, et al.
Publicado: (2017)

The long tail of oncogenic drivers in prostate cancer
por: Armenia, Joshua, et al.
Publicado: (2018)

Oncogenic Viruses as Entropic Drivers of Cancer Evolution
por: Tempera, Italo, et al.
Publicado: (2021)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

DriverDBv3: a multi-omics database for cancer driver gene research
por: Liu, Shu-Hsuan, et al.
Publicado: (2020)

Multi-omics analysis identifies drivers of protein phosphorylation
por: Zhang, Tian, et al.
Publicado: (2023)

Selective Inhibitors of Protein Methyltransferases
por: Kaniskan, H. Ümit, et al.
Publicado: (2014)

The Synergistic Effects of Curcumin and Chemotherapeutic Drugs in Inhibiting Metastatic, Invasive and Proliferative Pathways
por: Younes, Maria, et al.
Publicado: (2022)

The dissection of tomato flavor: biochemistry, genetics, and omics
por: Kaur, Gurleen, et al.
Publicado: (2023)

Dissecting the brain with spatially resolved multi-omics
por: Fangma, Yijia, et al.
Publicado: (2023)

An integrated genomics approach identifies drivers of proliferation in luminal subtype human breast cancer
por: Gatza, Michael L., et al.
Publicado: (2014)

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
por: Naramura, Mayumi, et al.
Publicado: (2011)

Targeting MET Amplification as a New Oncogenic Driver
por: Kawakami, Hisato, et al.
Publicado: (2014)

Bcl-x(L) is an oncogenic driver in colorectal cancer
por: Scherr, Anna-Lena, et al.
Publicado: (2016)

Ribosomal proteins: a novel class of oncogenic drivers
por: Sulima, Sergey O., et al.
Publicado: (2017)

Concomitant Pathogenic Mutations and Fusions of Driver Oncogenes in Tumors
por: Zhang, Runjiao, et al.
Publicado: (2021)

Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy: Avoiding Subretinal Persistence
por: Mowatt, Lizette
Publicado: (2013)

The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation
por: Cui, Jinfeng, et al.
Publicado: (2022)

Extensive Translational Regulation through the Proliferative Transition of Trypanosoma cruzi Revealed by Multi-Omics
por: Chávez, Santiago, et al.
Publicado: (2021)

Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion
por: Huang, Yulun, et al.
Publicado: (2021)

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
por: Turanli, Beste, et al.
Publicado: (2019)

Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes
por: Sudhakar, Malvika, et al.
Publicado: (2022)

Applications of Single-Cell Omics to Dissect Tumor Microenvironment
por: Guo, Tingting, et al.
Publicado: (2020)

Editorial: Dissecting antinutrient traits using omics approaches
por: Muthamilarasan, Mehanathan, et al.
Publicado: (2023)

Predicting Development of Proliferative Diabetic Retinopathy
por: Harris Nwanyanwu, Kristen, et al.
Publicado: (2013)

Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes
por: Leung, Kevin K., et al.
Publicado: (2020)

Leveraging protein quaternary structure to identify oncogenic driver mutations
por: Ryslik, Gregory A., et al.
Publicado: (2016)

CRAF R391W is a melanoma driver oncogene
por: Atefi, Mohammad, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4vlqgh629a8jg0h1hcf9r88evg